What does JANSSEN - CILAG INTERNATIONAL do?

JANSSEN - CILAG INTERNATIONAL is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Public Limited, started on 6 October 1997, 1 establishment.

What is the address of JANSSEN - CILAG INTERNATIONAL?

The registered office of JANSSEN - CILAG INTERNATIONAL is located at Turnhoutseweg 30, 2340 Beerse.

Is JANSSEN - CILAG INTERNATIONAL still active?

Yes. According to the CBE (29 October 2026) JANSSEN - CILAG INTERNATIONAL is active, legal situation “Normale toestand”, started on 6 October 1997.

Is JANSSEN - CILAG INTERNATIONAL registered on Peppol?

Yes, JANSSEN - CILAG INTERNATIONAL is registered on the Peppol network with ID 0208:0461607459.

What is the enterprise number of JANSSEN - CILAG INTERNATIONAL?

The enterprise number of JANSSEN - CILAG INTERNATIONAL is BE0461607459.

When was JANSSEN - CILAG INTERNATIONAL founded?

JANSSEN - CILAG INTERNATIONAL was founded on 6 October 1997.

Who are the directors of JANSSEN - CILAG INTERNATIONAL?

According to the 2025 annual accounts, the directors of JANSSEN - CILAG INTERNATIONAL are: Laurence Oster-Gozet, Elizabeth (Liz) Daly, Filip Elens, Alwin Otten, David Van Passel, Peter Willems, Patrick Laroche, Bart Philips.

Is JANSSEN - CILAG INTERNATIONAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 October 1997; 4 annual accounts filed, latest fiscal year 2025; 12 directors known from the annual account.

How much profit did JANSSEN - CILAG INTERNATIONAL make in 2025?

JANSSEN - CILAG INTERNATIONAL posted a profit after taxes of € 0 in financial year 2025.

What is the revenue of JANSSEN - CILAG INTERNATIONAL?

As a small company, JANSSEN - CILAG INTERNATIONAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,993.

JANSSEN - CILAG INTERNATIONAL (Public Limited) - Beerse

Dossier JANSSEN - CILAG INTERNATIONAL, printed on 29 October 2026 from databakkes.be/en/0461607459/janssen-cilag-international. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

JANSSEN - CILAG INTERNATIONAL from Beerse, company number BE0461607459, closed financial year 2025 with a result of € 0 after tax. For that financial year JANSSEN - CILAG INTERNATIONAL recorded a gross margin of € 1,993 and equity of € 165,897. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Healthy

€ 165,897

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit

€ 0

Profit after tax over the fiscal year.

Cash in the bank

€ 6,534

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 103,897.

Debts at end 2025

Bank debt

€ 158,130

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,923

▲ 102% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 60,339

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 5,027 Gross margin 2022: € 5,027 First fiscal year in the series	€ -2,883 Gross margin 2023: € -2,883 ▼ € 7,910 vs 2022 (€ 5,027) Unfavourable step	€ -4,928 Gross margin 2024: € -4,928 ▼ € 2,045 vs 2023 (€ -2,883) Unfavourable step	€ 1,993 Gross margin 2025: € 1,993 ▲ € 6,921 vs 2024 (€ -4,928) Favourable step	▲ € 6,921
Equity	€ 165,897 Equity 2022: € 165,897 First fiscal year in the series	€ 165,897 Equity 2023: € 165,897 Unchanged (€ 165,897) Unchanged	€ 165,897 Equity 2024: € 165,897 Unchanged (€ 165,897) Unchanged	€ 165,897 Equity 2025: € 165,897 Unchanged (€ 165,897) Unchanged
Total debts	€ 1,314 Total debts 2022: € 1,314 First fiscal year in the series	€ 24,903 Total debts 2023: € 24,903 ▲ € 23,589 vs 2022 (€ 1,314) Unfavourable step	€ 1,448 Total debts 2024: € 1,448 ▼ 94% vs 2023 (€ 24,903) Favourable step	€ 221,393 Total debts 2025: € 221,393 ▲ € 219,945 vs 2024 (€ 1,448) Unfavourable step	▲ € 219,945
Cash	€ 6,221 Cash 2022: € 6,221 First fiscal year in the series	€ 10,578 Cash 2023: € 10,578 ▲ 70% vs 2022 (€ 6,221) Favourable step	€ 5,365 Cash 2024: € 5,365 ▼ 49% vs 2023 (€ 10,578) Unfavourable step	€ 6,534 Cash 2025: € 6,534 ▲ 22% vs 2024 (€ 5,365) Favourable step	▲ 22%
Retained profit	€ 103,897 Retained profit 2022: € 103,897 First fiscal year in the series	€ 103,897 Retained profit 2023: € 103,897 Unchanged (€ 103,897) Unchanged	€ 103,897 Retained profit 2024: € 103,897 Unchanged (€ 103,897) Unchanged	€ 103,897 Retained profit 2025: € 103,897 Unchanged (€ 103,897) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 158,130 Bank debt 2025: € 158,130 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 167,211 Balance sheet total 2022: € 167,211 First fiscal year in the series	€ 190,800 Balance sheet total 2023: € 190,800 ▲ 14% vs 2022 (€ 167,211) Unchanged	€ 167,345 Balance sheet total 2024: € 167,345 ▼ 12% vs 2023 (€ 190,800) Unchanged	€ 387,289 Balance sheet total 2025: € 387,289 ▲ 131% vs 2024 (€ 167,345) Unchanged	▲ 131%

Key figures of JANSSEN - CILAG INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JANSSEN - CILAG INTERNATIONAL?

What happened at JANSSEN - CILAG INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Laurence Oster-Gozet stepped down as director. NBB
2031 David Van Passel stepped down as director. NBB
2031 Margarita Gomez Chantraine stepped down as director. NBB
2031 Mark Peturson stepped down as director. NBB
2030 Filip Elens stepped down as director. NBB
2030 Alwin Otten stepped down as director. NBB
2030 Catherine Michielsens stepped down as director. NBB
2030 Elena Bolaños Cascales stepped down as director. NBB

In short

From € 0 profit in 2022 to € 0 profit in 2025.

Original PDFs at the National Bank ↗

Management

Janssen Pharmaceutica NV 99%

Johnson & Johnson 1%

JANSSEN - CILAG INTERNATIONAL

The shares are held by Janssen Pharmaceutica NV (99%) and Johnson & Johnson (1%).

Directors

According to the 2025 annual accounts

Laurence Oster-Gozet

Director

since 2025 · until 2031

Elizabeth (Liz) Daly

Director

since 2024 · until 2025

Filip Elens

Director

since 2024 · until 2030

Alwin Otten

Director

since 2025 · until 2030

David Van Passel

Director

since 2025 · until 2031

Peter Willems

Chairman of the board

since 2023 · until 2029

Patrick Laroche

Director

since 2020 · until 2025

Bart Philips

Director

Also active at: Janssen Pharmaceutica

since 2022 · until 2025

Catherine Michielsens

Director

since 2024 · until 2030

Elena Bolaños Cascales

Director

since 2024 · until 2030

Margarita Gomez Chantraine

Director

since 2025 · until 2031

Mark Peturson

Director

since 2025 · until 2031

Shareholders

Janssen Pharmaceutica NV

99%

Johnson & Johnson

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Turnhoutseweg 30

2340 Beerse

2.103.100.847

Turnhoutsebaan 30

2340 Beerse

Active since 20 October 1997

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

Janssen Pharmaceutica same network

€ 21.8 billion revenue · 2025

J & J Pension Fund OFP

DR. PAUL JANSSEN MEDICAL INSTITUTE

J.C. GENERAL SERVICES

€ 80.9 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0461.607.459
VAT number: BE 0461.607.459
Registered office: Turnhoutseweg 30, 2340 Beerse
Names & denominations: Johnson & Johnson, J&J, Johnson & Johnson Innovative Medicine, J&J Innovative Medicine · JANSSEN - CILAG INTERNATIONAL
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 6 October 1997
Peppol: Active · Active since 18 Dec 2025
Activities · NACE: Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

JANSSEN - CILAG INTERNATIONAL

Financials

What happened to JANSSEN - CILAG INTERNATIONAL?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions